Vita Coco (COCO) director awarded 1,530 deferred RSUs, holds options
Rhea-AI Filing Summary
Vita Coco Company, Inc. director John Zupo reported an equity compensation grant and his current holdings. He received 1,530 deferred restricted stock units (RSUs), each representing one share of common stock, granted under the company’s 2021 Incentive Award Plan. These RSUs vest in full on the earlier of the day immediately preceding the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, provided he remains in continuous service, and will settle on June 3, 2031. Following this grant, he holds 13,692 shares of common stock directly. He also holds a fully vested, currently exercisable non-qualified stock option covering 20,675 shares of common stock at an exercise price of $10.178 per share, expiring on December 16, 2029.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,530 shares
Net Buy
2 txns
Insider
Zupo John
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,530 | $75.18 | $115K |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Common Stock — 13,692 shares (Direct);
Non-Qualified Stock Option (Right to Buy) — 20,675 shares (Direct)
Footnotes (2)
- F1. Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on June 3, 2031. Each deferred RSU represents the right to receive one share of common stock of the Issuer.
- F2. The stock option is fully vested and currently exercisable.
Key Figures
Deferred RSU grant: 1,530 units
Shares owned after grant: 13,692 shares
Option underlying shares: 20,675 shares
+3 more
6 metrics
Deferred RSU grant
1,530 units
Equity award reported on Form 4
Shares owned after grant
13,692 shares
Direct common stock holdings following transaction
Option underlying shares
20,675 shares
Non-qualified stock option for Vita Coco common stock
Option exercise price
$10.178 per share
Exercise price for non-qualified stock option
Option expiration
December 16, 2029
Expiration date of non-qualified stock option
RSU settlement date
June 3, 2031
Deferred RSUs settle into common shares on this date
Key Terms
Non-Qualified Stock Option (Right to Buy), deferred RSUs, 2021 Incentive Award Plan, vest in full, +1 more
5 terms
Non-Qualified Stock Option (Right to Buy) financial
"security_title: Non-Qualified Stock Option (Right to Buy)"
deferred RSUs financial
"Represents deferred RSUs granted under the company's 2021 Incentive Award Plan"
2021 Incentive Award Plan financial
"deferred RSUs granted under the company's 2021 Incentive Award Plan"
vest in full financial
"which vest in full the earlier of (i) the day immediately preceding"
continuous service financial
"provided that the Reporting Person remains in continuous service on the applicable vesting date"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Vita Coco (COCO) director John Zupo report on this Form 4?
John Zupo reported an equity compensation grant and updated holdings. The filing shows a grant of 1,530 deferred RSUs and discloses his direct common stock ownership and a fully vested stock option position that remains exercisable.
What are the vesting and settlement terms for John Zupo’s 1,530 Vita Coco RSUs?
The 1,530 deferred RSUs vest in full based on time and service. They vest on the earlier of the day immediately before the next Annual Stockholders Meeting after the grant date or the first anniversary, if he remains in continuous service, and settle on June 3, 2031.
What stock options does John Zupo hold in Vita Coco after this filing?
He holds a fully vested non-qualified stock option for 20,675 shares. The option has an exercise price of $10.178 per share, is currently exercisable, and carries an expiration date of December 16, 2029, providing long-term leveraged exposure to the stock.
Is John Zupo’s Vita Coco Form 4 an open-market stock purchase?
No, the Form 4 reflects an equity grant, not an open-market buy. The 1,530 units are deferred RSUs granted as compensation under the 2021 Incentive Award Plan, with specific vesting and settlement terms rather than a cash purchase on the market.